How to Create a Pharmaceutical Product Launch Plan

The Problem: Drug Launches Require Dozens of Teams to Hit the Same Date Simultaneously

FDA approval is not the finish line — it is the starting gun for the hardest 6 months of a drug's commercial life. From approval to commercial availability, a pharmaceutical launch requires: supply chain readiness (drug product at wholesalers), payer coverage secured (formulary placement and prior authorization criteria), sales force trained and deployed, patient services programs operational, medical affairs teams briefed on the label, and patient advocacy groups engaged. Any one of these not ready on Day 1 means lost revenue, lost patients, and lost competitive position.

The challenge is that each workstream has a different lead time and a different team. Supply chain decisions made 18 months before launch determine Day 1 inventory. Payer negotiations that didn't start 12 months out may not reach formulary placement until 6 months after launch. Coordinating all of this without a shared timeline visible to every function means the launch is managed by assumption, not by facts. gantt-chart.io aligns every function on the same launch date with the same view of what's done and what isn't.

Prerequisites

NDA/BLA submitted to FDA; PDUFA date known
Commercial strategy defined: target patient population, prescriber segments, pricing strategy
Brand name approved by FDA; labeling negotiations substantially complete
Manufacturing site approved or on track for pre-approval inspection
Cross-functional launch team formed with leads from commercial, medical, market access, supply chain, regulatory

Pharmaceutical Product Launch Plan Gantt Chart Template

Phase 1: Pre-Approval Launch Readiness (18–12 Months Before Approval)

[ ] Develop launch readiness framework; define readiness criteria by workstream
[ ] Initiate payer engagement: health economics and outcomes research (HEOR) data package, pricing strategy
[ ] Begin sales force planning: territory design, headcount, hiring timeline
[ ] Develop medical affairs publication plan; begin KOL engagement
[ ] Set up patient services infrastructure: hub services, patient assistance program
[ ] Manufacture validation batches; establish commercial supply agreements with CMOs

Phase 2: Market Access and Payer Strategy (12–6 Months Before Approval)

[ ] Submit dossiers to PBMs and commercial payers for formulary review
[ ] Negotiate contracts with PBMs for preferred formulary placement
[ ] Develop prior authorization criteria with medical affairs; brief payer medical directors
[ ] Engage state Medicaid programs; initiate supplemental rebate negotiations
[ ] Develop reimbursement support tools for physician offices
[ ] Set up specialty pharmacy network if required; negotiate distribution agreements

Phase 3: Commercial Launch Preparation (6–3 Months Before Approval)

[ ] Hire and train sales force; complete product knowledge and selling skills certification
[ ] Develop promotional materials; submit to OPDP for advisory review
[ ] Set up CRM and call planning systems; load target prescriber lists
[ ] Train medical science liaisons (MSLs) on clinical data; deploy to key accounts
[ ] Finalize drug pricing; submit to wholesaler drug databases (FDB, Medi-Span)
[ ] Set up adverse event reporting system; train customer-facing staff on pharmacovigilance

Phase 4: Approval and Immediate Launch Activation (0–4 Weeks Post-Approval)

[ ] Upon approval, issue press release and notify HCP community via medical affairs
[ ] Activate supply chain: ship to wholesalers and specialty pharmacies
[ ] Deploy sales force; begin physician office calls
[ ] Activate patient services hub; begin intake of patient enrollment forms
[ ] Issue formulary status communications to prescribers
[ ] Launch patient-facing digital and DTC campaigns if approved in promotional plan

Phase 5: Post-Launch Optimization (Months 1–6)

[ ] Track weekly prescription data (IQVIA, Symphony Health); adjust sales force deployment
[ ] Monitor pull-through of formulary wins; address access barriers as they emerge
[ ] Track patient persistence and discontinuation rates; optimize adherence programs
[ ] Submit 4-month post-marketing study commitments on schedule
[ ] Conduct 90-day launch review with all functions; adjust tactics based on field feedback

Common Pitfalls

Payer engagement starting too late: Formulary decisions for the following year are made 12–18 months in advance. A drug approved in Q1 may not achieve broad commercial coverage until the following year's formulary cycle if payer work started at approval.
Supply chain not scaled to forecasted demand: Manufacturing campaigns take months to plan and execute. If demand forecasts are conservative to manage risk, stock-outs on a successful launch destroy the growth trajectory.
Sales force hiring tied to PDUFA date: Sales hiring and training takes 3–4 months. Tying the start of hiring to FDA approval means the field is not ready to promote for the first quarter of commercialization.
Medical affairs and commercial not aligned on messaging: MSLs and sales reps with inconsistent messages to HCPs undermine credibility. Message alignment meetings must happen before field deployment, not after.

What Good Looks Like

A well-executed pharmaceutical launch achieves 80%+ commercial payer coverage within 90 days of approval, has inventory at wholesalers on Day 1, and sees its sales force in front of priority prescribers within the first week. TRx trends in weeks 2–4 follow the forecast curve, patient services enrollment is frictionless, and the medical affairs team has already published the key data package that drives HCP confidence. The launch team debriefs at 90 days with real data, not anecdotes.